Search Results

There are 3747 results for: content related to: Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory

  1. Predictors of recall certainty of dates of analgesic medication use in pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 25–32, Rose G. Radin, Allen A. Mitchell and Martha M. Werler

    Article first published online : 4 JUN 2012, DOI: 10.1002/pds.3300

  2. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  3. Risk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study

    Pharmacoepidemiology and Drug Safety

    Chao-Feng Lin, Hung-Yi Chiou, Ya-Hui Chang, Ju-Chi Liu, Yen-Ni Hung, Ming-Tsang Chuang and Li-Nien Chien

    Article first published online : 22 JAN 2016, DOI: 10.1002/pds.3963

  4. Risk factors for venous thromboembolism during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 12, December 2013, Pages: 1283–1291, Thomas Bo Jensen, Thomas Alexander Gerds, Randi Grøn, Ditte-Marie Bretler, Michelle Dalgas Schmiegelow, Charlotte Andersson, Aziza Azimi, Gunnar Gislason, Christian Torp-Pedersen and Jonas Bjerring Olesen

    Article first published online : 16 OCT 2013, DOI: 10.1002/pds.3536

  5. Preadmission use of renin–angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 141–150, Holger Wemmelund, Annette Høgh, Heidi H. Hundborg, Søren P. Johnsen and Jes S. Lindholt

    Article first published online : 17 NOV 2015, DOI: 10.1002/pds.3913

  6. The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 10, October 2015, Pages: 1049–1057, James A. Feinstein, Chris Feudtner, Robert J. Valuck and Allison Kempe

    Article first published online : 7 AUG 2015, DOI: 10.1002/pds.3843

  7. Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case–control study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1173–1182, Sascha Dublin, Rod L. Walker, Michael L. Jackson, Jennifer C. Nelson, Noel S. Weiss and Lisa A. Jackson

    Article first published online : 5 SEP 2012, DOI: 10.1002/pds.3340

  8. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377

  9. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Article first published online : 25 NOV 2015, DOI: 10.1002/pds.3912

  10. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1027–1035, Farshad Kajbaf, Paul Arnouts, Marc de Broe and Jean-Daniel Lalau

    Article first published online : 19 AUG 2013, DOI: 10.1002/pds.3501

  11. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Article first published online : 23 FEB 2012, DOI: 10.1002/pds.3219

  12. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Article first published online : 28 JAN 2016, DOI: 10.1002/pds.3966

  13. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  14. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Article first published online : 27 JAN 2014, DOI: 10.1002/pds.3566

  15. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Article first published online : 13 SEP 2013, DOI: 10.1002/pds.3508

  16. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Article first published online : 2 NOV 2015, DOI: 10.1002/pds.3880

  17. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 161–169, Maarit Jaana Korhonen, Päivi Ruokoniemi, Jenni Ilomäki, Atte Meretoja, Arja Helin-Salmivaara and Risto Huupponen

    Article first published online : 21 DEC 2015, DOI: 10.1002/pds.3936

  18. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Article first published online : 12 JUL 2013, DOI: 10.1002/pds.3480

  19. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 560–571, Shibing Yang, Charles B. Eaton, Juan Lu and Kate L. Lapane

    Article first published online : 24 JAN 2014, DOI: 10.1002/pds.3569

  20. You have free access to this content
    Testosterone prescribing in the population—a short social epidemiological analysis in Sweden

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 1, January 2016, Pages: 11–15, Pernilla J. Bjerkeli, Shai Mulinari and Juan Merlo

    Article first published online : 28 JUL 2015, DOI: 10.1002/pds.3836